Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

MedExecWomen Empowers Women in Leadership Roles in the Medical Device Diagnostics and Digital Health Industries

MedExecWomen, an organization dedicated to empowering women in leadership roles in the medical device, diagnostics, drug delivery, and digital healthcare industries, hosted the second annual MedExecWomen conference on October 26, 2021, in Boston, MA.

The event brought together executives and thought leaders from Johnson & Johnson, Boston Scientific, Medtronic, GE Healthcare, 3M Health Information Systems, Mass General Brigham, New England Baptist, United Health Group, Tufts Medical, and the Bill & Melinda Gates Foundation. Topics discussed during the agenda covered medical innovation strategies in a post-COVID world.

Helen Routh, Board President of MedExecWomen said “Innovation in healthcare, particularly post COVID, requires us to work across industry sectors, alongside clinicians and payers. MedExecWomen does just this – sharing learnings and building networks with peers that will drive further improvements in outcomes.”

“We founded MedExecWomen to be a forum for senior leaders to network – to learn and engage with peers in the medtech world. We were so pleased to be back together after 18 months, and we look forward to our next opportunity to gather in spring/early summer of 2022,” said Laurie Halloran of Halloran Consulting Group.

Maria Shepherd of Medi-Vantage said, “We had an amazing turnout with over one hundred women attending the MedExecWomen meeting. Our speakers were leading physicians and experts from the medical device industry.”

MedExecWomen supports female executives by creating venues to network, refine leadership skills, and develop relevant expertise. The organization strives to:

  • Increase the value brought to healthcare by female executives
  • Strengthen future gender diversity through a connected, effective, and visible female leadership pool
  • Support female executives as they navigate ambiguity and complexity to lead in rapidly changing markets

MedExecWomen’s third annual conference will be held June 14, 2022, in Boston, MA.


Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy